Insights
-
The Relevance of Intellectual Property for Pharmaceutical Innovation
By Mr Maarten Meulenbelt, Sidley Austin LLP* In the pharmaceutical industry, the role of Intellectual Property (IP) as an incentive for product development is particularly important: each investor...
-
The European Commission’s Pharmaceutical Innovation Incentives Review Is at Risk of Serious Overreach
Philip Stevens is executive director of Geneva Network, a UK-based research organisation working on international innovation and trade policy. Over the summer, the European Commission (EC)...